Global Bioengineered Protein Drugs Market Research Report 2022, Forecast to 2027
SKU ID :MMI-20973867 | Published Date: 24-May-2022 | No. of pages: 135Description
TOC
Table of Contents
Global Bioengineered Protein Drugs Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Bioengineered Protein Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Bioengineered Protein Drugs Segment by Type
2.1.1 Recombinant protein drugs
2.1.2 Peptide hormones
2.1.3 Vaccines
2.1.4 Therapeutic enzymes
2.1.5 Monoclonal antibodies
2.1.6 Cytokines
2.1.7 Replacement proteins
2.1.8 Peptide antibiotics
2.1.9 Blood products
2.2 Market Analysis by Application
2.2.1 Fractionation
2.2.2 Bioreactors and microbial cell fermentation
2.2.3 Genetic engineering
2.2.4 Genetically modified organisms
2.2.5 Pharming
2.2.6 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
2.2.7 Cell culture
2.2.8 Others
2.3 Global Bioengineered Protein Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global Bioengineered Protein Drugs Market Size (2017-2027)
2.3.2 North America Bioengineered Protein Drugs Status and Prospect (2017-2027)
2.3.3 Europe Bioengineered Protein Drugs Status and Prospect (2017-2027)
2.3.4 China Bioengineered Protein Drugs Status and Prospect (2017-2027)
2.3.5 Japan Bioengineered Protein Drugs Status and Prospect (2017-2027)
2.3.6 Southeast Asia Bioengineered Protein Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Bioengineered Protein Drugs Industry Impact
2.5.1 Bioengineered Protein Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Bioengineered Protein Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Bioengineered Protein Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Bioengineered Protein Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Bioengineered Protein Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Bioengineered Protein Drugs Manufacturer Market Share
3.5 Top 10 Bioengineered Protein Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Bioengineered Protein Drugs Market
3.7 Key Manufacturers Bioengineered Protein Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Bioengineered Protein Drugs Industry Key Manufacturers
4.1 Abbot
4.1.1 Compan Detail
4.1.2 Abbot Bioengineered Protein Drugs Product Introduction, Application and Specification
4.1.3 Abbot 135 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Abbot News
4.2 Amgen
4.2.1 Compan Detail
4.2.2 Amgen Bioengineered Protein Drugs Product Introduction, Application and Specification
4.2.3 Amgen Bioengineered Protein Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Abbot News
4.3 Baxter
4.3.1 Compan Detail
4.3.2 Baxter Bioengineered Protein Drugs Product Introduction, Application and Specification
4.3.3 Baxter Bioengineered Protein Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Baxter News
4.4 Bayer
4.4.1 Compan Detail
4.4.2 Bayer Bioengineered Protein Drugs Product Introduction, Application and Specification
4.4.3 Bayer Bioengineered Protein Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Bayer News
4.5 Eli Lilly
4.5.1 Compan Detail
4.5.2 Bayer Bioengineered Protein Drugs Product Introduction, Application and Specification
4.5.3 Eli Lilly Bioengineered Protein Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Eli Lilly News
4.6 GlaxoSmithKline
4.6.1 Compan Detail
4.6.2 GlaxoSmithKline Bioengineered Protein Drugs Product Introduction, Application and Specification
4.6.3 GlaxoSmithKline Bioengineered Protein Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 GlaxoSmithKline News
4.7 Fresenius Kabi
4.7.1 Compan Detail
4.7.2 Fresenius Kabi Bioengineered Protein Drugs Product Introduction, Application and Specification
4.7.3 Fresenius Kabi Bioengineered Protein Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Hoffman-la-Roche
4.8.1 Compan Detail
4.8.2 Hoffman-la-Roche Bioengineered Protein Drugs Product Introduction, Application and Specification
4.8.3 Hoffman-la-Roche Bioengineered Protein Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Hoffman-la-Roche News
4.9 Johnson & Johnson
4.9.1 Compan Detail
4.9.2 Johnson & Johnson Bioengineered Protein Drugs Product Introduction, Application and Specification
4.9.3 Johnson & Johnson Bioengineered Protein Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Johnson & Johnson News
4.10 Merck
4.10.1 Compan Detail
4.10.2 Merck Bioengineered Protein Drugs Product Introduction, Application and Specification
4.10.3 Merck Bioengineered Protein Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Merck News
5 Global Bioengineered Protein Drugs Market Segment by Big Type
5.1 Global Bioengineered Protein Drugs Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Bioengineered Protein Drugs Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Bioengineered Protein Drugs Revenue and Market Share by Big Type (2017-2022)
5.2 Recombinant protein drugs Sales Growth Rate and Price
5.2.1 Global Recombinant protein drugs Sales Growth Rate (2017-2022)
5.2.2 Global Recombinant protein drugs Price (2017-2022)
5.3 Peptide hormones Sales Growth Rate and Price
5.3.1 Global Peptide hormones Sales Growth Rate (2017-2022)
5.3.2 Global Peptide hormones Price (2017-2022)
5.4 Vaccines Sales Growth Rate and Price
5.4.1 Global Vaccines Sales Growth Rate (2017-2022)
5.4.2 Global Vaccines Price (2017-2022)
5.5 Therapeutic enzymes Sales Growth Rate and Price
5.5.1 Global Therapeutic enzymes Sales Growth Rate (2017-2022)
5.5.2 Global Therapeutic enzymes Price (2017-2022)
5.6 Monoclonal antibodies Sales Growth Rate and Price
5.6.1 Global Monoclonal antibodies Sales Growth Rate (2017-2022)
5.6.2 Global Monoclonal antibodies Price (2017-2022)
5.7 Cytokines Sales Growth Rate and Price
5.7.1 Global Cytokines Sales Growth Rate (2017-2022)
5.7.2 Global Cytokines Price (2017-2022)
5.8 Replacement proteins Sales Growth Rate and Price
5.8.1 Global Replacement proteins Sales Growth Rate (2017-2022)
5.8.2 Global Replacement proteins Price (2017-2022)
5.9 Peptide antibiotics Sales Growth Rate and Price
5.9.1 Global Peptide antibiotics Sales Growth Rate (2017-2022)
5.9.2 Global Peptide antibiotics Price (2017-2022)
5.10 Blood products Sales Growth Rate and Price
5.10.1 Global Blood products Sales Growth Rate (2017-2022)
5.10.2 Global Blood products Price (2017-2022)
6 Global Bioengineered Protein Drugs Market Segment by Big Application
6.1 Global Bioengineered Protein Drugs Sales Market Share by Big Application (2017-2022)
6.2 Fractionation Sales Growth Rate (2017-2022)
6.3 Bioreactors and microbial cell fermentation Sales Growth Rate (2017-2022)
6.4 Genetic engineering Sales Growth Rate (2017-2022)
6.5 Genetically modified organisms Sales Growth Rate (2017-2022)
6.6 Pharming Sales Growth Rate (2017-2022)
6.7 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals Sales Growth Rate (2017-2022)
6.8 Cell culture Sales Growth Rate (2017-2022)
6.9 Others Sales Growth Rate (2017-2022)
7 Global Bioengineered Protein Drugs Forecast
7.1 Global Bioengineered Protein Drugs Revenue, Sales and Growth Rate (2022-2027)
7.2 Bioengineered Protein Drugs Market Forecast by Regions (2022-2027)
7.2.1 North America Bioengineered Protein Drugs Market Forecast (2022-2027)
7.2.2 Europe Bioengineered Protein Drugs Market Forecast (2022-2027)
7.2.3 China Bioengineered Protein Drugs Market Forecast (2022-2027)
7.2.4 Japan Bioengineered Protein Drugs Market Forecast (2022-2027)
7.2.5 Southeast Asia Bioengineered Protein Drugs Market Forecast (2022-2027)
7.2.6 Other Regions Bioengineered Protein Drugs Market Forecast (2022-2027)
7.3 Bioengineered Protein Drugs Market Forecast by Type (2022-2027)
7.3.1 Global Bioengineered Protein Drugs Sales Forecast by Type (2022-2027)
7.3.2 Global Bioengineered Protein Drugs Market Share Forecast by Type (2022-2027)
7.4 Bioengineered Protein Drugs Market Forecast by Application (2022-2027)
7.4.1 Global Bioengineered Protein Drugs Sales Forecast by Application (2022-2027)
7.4.2 Global Bioengineered Protein Drugs Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Bioengineered Protein Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Bioengineered Protein Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
Tables & Figures
List of Tables and Figures
Figure Product Picture Bioengineered Protein Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Bioengineered Protein Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Bioengineered Protein Drugs Market Size by Big Type
Figure Global Market Share of Bioengineered Protein Drugs by Big Type in 2021
Figure Recombinant protein drugs Picture (2017-2022)
Figure Peptide hormones Picture (2017-2022)
Figure Vaccines Picture (2017-2022)
Figure Therapeutic enzymes Picture (2017-2022)
Figure Monoclonal antibodies Picture (2017-2022)
Figure Cytokines Picture (2017-2022)
Figure Replacement proteins Picture (2017-2022)
Figure Peptide antibiotics Picture (2017-2022)
Global Bioengineered Protein Drugs Market Size by Big Application
Table Global Bioengineered Protein Drugs Market Size by Application
Figure Global Bioengineered Protein Drugs Market Share by Big Application in 2021
Figure Fractionation Picture
Figure Bioreactors and microbial cell fermentation Picture
Figure Genetic engineering Picture
Figure Genetically modified organisms Picture
Figure Pharming Picture
Figure Bioengineered protein drugs produced by transgenic microorganisms, plants and animals Picture
Figure Cell culture Picture
Figure Others Picture
Table Global Bioengineered Protein Drugs Comparison by Regions (M USD) (2017-2027)
Figure Global Bioengineered Protein Drugs Market Size (Million US$) (2017-2027)
Figure North America Bioengineered Protein Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Bioengineered Protein Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure China Bioengineered Protein Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Bioengineered Protein Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Bioengineered Protein Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Bioengineered Protein Drugs Sales by Manufacturer (2017-2022)
Figure Global Bioengineered Protein Drugs Sales Market Share by Manufacturer in 2021
Table Global Bioengineered Protein Drugs Revenue by Manufacturer (2017-2022)
Figure Global Bioengineered Protein Drugs Revenue Market Share by Manufacturer in 2021
Table Global Bioengineered Protein Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Bioengineered Protein Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Bioengineered Protein Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Bioengineered Protein Drugs Market
Table Key Manufacturers Bioengineered Protein Drugs Product Type
Table Mergers & Acquisitions Planning
Table Abbot Company Profile
Table Bioengineered Protein Drugs Product Introduction, Application and Specification of Abbot
Table Bioengineered Protein Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Amgen Company Profile
Table Bioengineered Protein Drugs Product Introduction, Application and Specification of Amgen
Table Bioengineered Protein Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Amgen Recent Development
Table Baxter Company Profile
Table Bioengineered Protein Drugs Product Introduction, Application and Specification of Baxter
Table Bioengineered Protein Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Baxter Main Business
Table Baxter Recent Development
Table Bayer Company Profile
Table Bioengineered Protein Drugs Product Introduction, Application and Specification of Bayer
Table Bioengineered Protein Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer Main Business
Table Bayer Recent Development
Table Bayer Main Business
Table Bayer Recent Development
Table Eli Lilly Company Profile
Table Bioengineered Protein Drugs Product Introduction, Application and Specification of Eli Lilly
Table Bioengineered Protein Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Profile
Table Bioengineered Protein Drugs Product Introduction, Application and Specification of GlaxoSmithKline
Table Bioengineered Protein Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Fresenius Kabi Company Profile
Table Bioengineered Protein Drugs Product Introduction, Application and Specification of Fresenius Kabi
Table Bioengineered Protein Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Fresenius Kabi Main Business
Table Fresenius Kabi Recent Development
Table Hoffman-la-Roche Company Profile
Table Bioengineered Protein Drugs Product Introduction, Application and Specification of Hoffman-la-Roche
Table Bioengineered Protein Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hoffman-la-Roche Main Business
Table Hoffman-la-Roche Recent Development
Table Johnson & Johnson Company Profile
Table Bioengineered Protein Drugs Product Introduction, Application and Specification of Johnson & Johnson
Table Bioengineered Protein Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Merck Company Profile
Table Bioengineered Protein Drugs Product Introduction, Application and Specification of Merck
Table Bioengineered Protein Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Figure Global Bioengineered Protein Drugs Sales and Growth Rate (2017-2022)
Figure Global Bioengineered Protein Drugs Revenue and Growth Rate (2017-2022)
Table Global Bioengineered Protein Drugs Sales by Regions (2017-2022)
Figure Global Bioengineered Protein Drugs Sales Market Share by Regions in 2021
Table Global Bioengineered Protein Drugs Revenue by Regions (2017-2022)
Figure Global Bioengineered Protein Drugs Revenue Market Share by Regions in 2021
Figure North America Bioengineered Protein Drugs Sales and Growth Rate (2017-2022)
Figure Europe Bioengineered Protein Drugs Sales and Growth Rate (2017-2022)
Figure China Bioengineered Protein Drugs Sales and Growth Rate (2017-2022)
Figure Japan Bioengineered Protein Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia Bioengineered Protein Drugs Sales and Growth Rate (2017-2022)
Figure Other Regions Bioengineered Protein Drugs Sales and Growth Rate (2017-2022)
Table Global Bioengineered Protein Drugs Sales by Big Type (2017-2022)
Table Global Bioengineered Protein Drugs Sales Market Share by Big Type (2017-2022)
Figure Global Bioengineered Protein Drugs Sales Market Share by Big Type in 2019
Table Global Bioengineered Protein Drugs Revenue by Big Type (2017-2022)
Table Global Bioengineered Protein Drugs Revenue Market Share by Big Type (2017-2022)
Table Global Bioengineered Protein Drugs Revenue Market Share by Big Type in 2019
Figure Global Recombinant protein drugs Sales Growth Rate (2017-2022)
Figure Global Recombinant protein drugs Price (2017-2022)
Figure Global Peptide hormones Sales Growth Rate (2017-2022)
Figure Global Peptide hormones Price (2017-2022)
Figure Global Vaccines Sales Growth Rate (2017-2022)
Figure Global Vaccines Price (2017-2022)
Figure Global Therapeutic enzymes Sales Growth Rate (2017-2022)
Figure Global Therapeutic enzymes Price (2017-2022)
Figure Global Cytokines Sales Growth Rate (2017-2022)
Figure Global Cytokines Price (2017-2022)
Figure Global Replacement proteins Sales Growth Rate (2017-2022)
Figure Global Replacement proteins Price (2017-2022)
Figure Global Peptide antibiotics Sales Growth Rate (2017-2022)
Figure Global Peptide antibiotics Price (2017-2022)
Figure Global Blood products Sales Growth Rate (2017-2022)
Table Global Bioengineered Protein Drugs Sales by Big Application (2017-2022)
Table Global Bioengineered Protein Drugs Sales Market Share by Big Application (2017-2022)
Figure Global Bioengineered Protein Drugs Sales Market Share by Big Application in 2019
Figure Global Fractionation Sales Growth Rate (2017-2022)
Figure Global Bioreactors and microbial cell fermentation Sales Growth Rate (2017-2022)
Figure Global Genetic engineering Sales Growth Rate (2017-2022)
Figure Global Genetically modified organisms Sales Growth Rate (2017-2022)
Figure Global Pharming Sales Growth Rate (2017-2022)
Figure Global Bioengineered protein drugs produced by transgenic microorganisms, plants and animals Sales Growth Rate (2017-2022)
Figure Global Cell culture Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Bioengineered Protein Drugs Sales and Growth Rate (2022-2027)
Figure Global Bioengineered Protein Drugs Revenue and Growth Rate (2022-2027)
Table Global Bioengineered Protein Drugs Sales Forecast by Regions (2022-2027)
Table Global Bioengineered Protein Drugs Market Share Forecast by Regions (2022-2027)
Figure North America Sales Bioengineered Protein Drugs Market Forecast (2022-2027)
Figure Europe Sales Bioengineered Protein Drugs Market Forecast (2022-2027)
Figure China Sales Bioengineered Protein Drugs Market Forecast (2022-2027)
Figure Japan Sales Bioengineered Protein Drugs Market Forecast (2022-2027)
Figure Southeast Asia Sales Bioengineered Protein Drugs Market Forecast (2022-2027)
Figure Other Regions Sales Bioengineered Protein Drugs Market Forecast (2022-2027)
Table Global Bioengineered Protein Drugs Sales Forecast by Type (2022-2027)
Table Global Bioengineered Protein Drugs Market Share Forecast by Type (2022-2027)
Table Global Bioengineered Protein Drugs Sales Forecast by Application (2022-2027)
Table Global Bioengineered Protein Drugs Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bioengineered Protein Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Bioengineered Protein Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Bioengineered Protein Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Bioengineered Protein Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Bioengineered Protein Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Bioengineered Protein Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Bioengineered Protein Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Bioengineered Protein Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Bioengineered Protein Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Companies
Abbot
Amgen
Baxter
Bayer
Eli Lilly
GlaxoSmithKline
Fresenius Kabi
Hoffman-la-Roche
- PRICE
-
$2680$5360$3800Buy Now